2026년 9월 17일•3분 읽기
Asia Becomes New Hub for Global New‑Drug Development
Asia’s biotech ecosystem, bolstered by government investment and regulatory reforms, now accounts for about 43% of the global innovative therapy pipeline, shifting R&D focus from the US and Europe.